Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Podcast: Using Antipsychotic Plasma Levels to Guide Schizophrenia Treatment With Jonathan M. Meyer, MD
2
The First Ever Treatment-Resistant Depression Awareness Day
3
Can Durable Response to Psilocybin Reshape Treatment-Resistant Depression Care?
4
Trees in the Forest of Depression
5